Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls

• Conditions: Ischemic Stroke

• Registration Number: NCT01487746
• Lead Sponsor: Meir Medical Center

Brief Summary

The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies.

The investigators believe that minor antibodies have a major role in the hypercoagulability state.

Detailed Description

Not available

Study Timeline

• Status Verified: 2011-12
• Study Start: 2011-12
• Study First Submitted: 2011-12-05
• Study First Submitted QC: 2011-12-06
• Last Update Submitted: 2011-12-06
• Study First Posted: 2011-12-07
• Last Update Posted: 2011-12-07
• Primary Completion: 2012-03
• Study Completion: 2012-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 207

Inclusion Criteria

• stroke diagnosis
• blood sampling within 36hrs from the event
• written agreement

Exclusion Criteria

• a stroke, MI or major operation prior to the current stroke
• hypercoagulable state known in this patient
• a severe chronic disease known at the time of the stroke
• an infection on arrival (based on anamnesis, physical exam and lab tests)
• thrombolytic treatment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Meir health center; 🇮🇱 Kfar-saba, Israel